Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Mouse stem cells from hair follicles can improve wound healing and reduce scarring.

Alternative treatments show promise for hair growth beyond traditional methods.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

A 1-day or 3-day itraconazole treatment is effective for acute vulvovaginal candidosis, but recurrent cases may need longer treatment.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

A patient with zinc depletion improved after zinc supplementation during parenteral nutrition.

Modified KGF mRNA helps skin cells grow and move faster, which may improve wound healing.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

New antiscarring strategies show promise, including drugs, stem cells, and improved surgical techniques.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that hair loss in cats is caused by various factors, including allergies, mites, infections, and hormonal issues, with treatments varying accordingly.

Exosome therapy may help treat diabetic nerve damage, but more research is needed.

Photobiomodulation therapy can reduce pain and inflammation and help heal tissues, but more research is needed to improve its effectiveness and safety.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Standardized methods are needed to understand how process conditions affect extracellular vesicle protein content for skin therapy.

PRP therapy shows promise for anti-aging but lacks consistent evidence and standardization.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.